Involvement of Tumor Necrosis Factor- and Nuclear Factor- B Activation
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Alveolar macrophages play a critical role in silica-induced lung
fibrosis. Silica exposure induces tumor necrosis factor (TNF)-
release and nuclear factor (NF)-
B activation, and apoptotic
mechanisms have been implicated in silica-induced pathogenesis. To characterize potential relationships between these signaling events, we studied their induction in two murine macrophage cell lines. The RAW 264.7 macrophage cell line was
more sensitive, and the IC-21 macrophage cell line more tolerant to silica exposure (0.2 or 1 mg/ml for 6 h) as evidenced
by significantly higher apoptotic responses in RAW 264.7 (P < 0.05). RAW 264.7 macrophages exhibited enhanced TNF-
production and NF-
B activation in response to silica, whereas IC-21
macrophages did not produce TNF-
in response to silica and
did not induce NF-
B nuclear binding. Inhibition of NF-
B in
RAW 264.7 cells with BAY11-7082 significantly increased apoptosis while inhibiting TNF-
release. In addition, TNF-
and
NF-
B activation, but not apoptosis, were induced by lipopolysaccharide (LPS) in both cell lines, and NF-
B inhibition reduced
LPS-induced TNF-
release. These data suggest that TNF-
induction is dependent on NF-
B activation in both cell lines.
However, silica can induce apoptosis in murine macrophages,
independently of TNF-
stimulation, as in IC-21 macrophages.
Furthermore, NF-
B activation in macrophages may play dual
roles, both pro- and antiapoptotic during silica injury.
| |
Introduction |
|---|
|
|
|---|
Exposure to silica dust induces lung inflammation which
may progress to lung fibrosis, a disease known as silicosis.
Although the exact mechanisms leading to silicosis have
yet to be elucidated, current evidence suggests that the alveolar macrophage plays a critical role in the development
of inflammation and fibrosis. Alveolar macrophages isolated from patients with pulmonary fibrosis are activated,
and release a variety of fibrogenic factors and cytokines
(1, 2, 3). Among these cytokines, tumor necrosis factor
(TNF)-
emerges as a crucial modulator of the inflammatory and fibrogenic response to silica exposure (4, 5).
When macrophages are exposed to silica in vitro, enhanced TNF-
production occurs (6, 7). Increase in TNF-
production, in turn, activates an inflammatory response
cascade by altering the transcriptional regulation of several genes involved in fibrogenesis including other cytokines, fibronectin, collagen, and TNF-
itself (2, 7, 8).
Treatment of silica-exposed mice with an anti-TNF-
antibody significantly reduces collagen deposition in the lung and, conversely, infusion of recombinant TNF-
increases
collagen deposition in the lungs of mice (4). In addition,
overexpression of TNF-
in the lung of transgenic mice resulted in alveolar disruption and mild pulmonary fibrosis
(5). Thus, silica-induced lung disease appears to be critically dependent on TNF-
gene activation by alveolar macrophages.
Several studies have recently suggested that apoptotic
mechanisms are involved in the development of silica-induced pathologic changes (12). However, the signal
transduction pathways involved in TNF-
induction by silica in the alveolar macrophage are presently unclear. For
example, in murine peritoneal macrophages, the TNF-
gene
promoter contains four nuclear factor (NF)-
B-binding
sequences (16, 17), but it is likely that other regulatory elements such as AP-1, AP-2, CRE, Egr-1, and Sp-1, which
have been identified in a region of the human monocyte
promoter that is highly homologous to the mouse TNF-
promoter, may also be involved (18, 19). This evidence
linking NF-
B activation to silica exposure in the alveolar
macrophage and TNF-
-induced cytotoxic effects would suggest that the putative role of NF-
B activation may involve antiapototic pathways (10, 11, 20).
NF-
B has been implicated in proapoptotic as well as
antiapoptotic pathways, depending on the cell type and the
stimulus (21). Thus, assessment of silica-induced NF-
B
activation and TNF-
production in the macrophage, and
their correlation to silica induction of apoptosis, could add
to the current understanding of the intracellular signaling
pathways underlying silica-induced fibrogenesis.
The susceptibility to silica-induced injury differs among
mouse strains, as evidenced by varying degrees of pulmonary fibrosis, ranging from minimal to severe (25, 26). We
have recently shown that gene disruption of the TNF receptor was associated with markedly reduced lung fibrosis
following silica exposure (27). In addition, silica exposure
enhanced NF-
B nuclear binding in the mouse lung (28).
Based on these studies, we hypothesized that a mechanism
underlying the strain susceptibility differences to silica
may involve upstream signaling pathways regulating TNF-
gene expression. Macrophage apoptosis is an early event
in the pathogenesis of silica injury. The study of silica-induced lung injury requires a better understanding of the
signaling pathways underlying tolerance and vulnerability
of the macrophage response to silica injury. To address these
issues, we identified two murine macrophage-derived cell
lines that differ in their TNF-
and apoptotic responses to
silica in vitro. RAW 264.7 macrophages exhibit enhanced TNF-
production and NF-
B activation in response to
silica. In contrast, IC-21 macrophages do not produce
TNF-
in response to silica and do not induce NF-
B. However, both IC-21 and RAW 264.7 macrophages are able to
phagocytize silica particles (29), and induce TNF-
production and NF-
B activation in response to lipopolysaccharide (LPS). We therefore employed this novel paradigm to
further examine relationships between silica-induced
apoptosis, TNF-
production, and NF-
B activation.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture, Silica Exposure, and TNF-
Determination
The mouse macrophage-like cell lines RAW 264.7 (derived from
BALB/c mouse; TIB 71) and IC-21 (derived from C57BL/6
mouse; TIB 186) were purchased from the American Type Culture Collection (Rockville, MD), and cultured in DMEM and
RPMI 1640 medium (Gibco BRL, Rockville, MD) respectively,
supplemented with 10% FCS, 1% glutamine, 1% penicillin, and
1% streptomycin. Silica particles < 1 µm were selected by sedimentation according to Stokes' law, acid hydrolyzed, and baked
overnight. For stimulation experiments cells were seeded in 6-well
plates at 3-5 × 105 cells/cm2, grown for 3 d, and exposed to 0.2 or
1 mg/ml silica for 6 or 24 h in duplicate wells. Untreated cells
were used as negative controls and cells were exposed to LPS (2 µg/ml; Sigma, St Louis, MO) as positive control. Cell viability
was verified by trypan blue exclusion. Following exposure, culture supernatants were collected for measurements of TNF-
using a commercially available enzyme-linked immunosorbent assay
(ELISA) kit (Pierce-Endogen, Rockford, IL). Cells were scraped
in 1 ml PBS, collected by centrifugation, and resuspended in
adequate lysis buffer for electrophoretic mobility shift assay (EMSA)
analysis. For apoptosis detection, a Cell Death Plus ELISA kit
was used according to the manufacturer's instructions (Roche
Molecular Biochemicals, Indianapolis, IN).
Detection of Apoptosis
3-5 × 105 cells/cm2 grown for 3 d in 6 wells and exposed to 0.2 or
1 mg/ml silica for 6 h in duplicate wells floating and adherent cells
were pooled and lysed with 500 µl of lysis buffer (1% SDS, 10 mM Tris, pH 7.4) for 30 min. Lysed cells were transferred to 1.5-ml
Eppendorf tubes and centrifuged at 1,000 × g for 10 min to separate low molecular weight DNA (oligonucleosome-sized fragments derived from apoptotic cells) from high molecular weight
DNA (from viable cells). A 20-µl aliquot of a 1:5 dilution of the
supernatant containing oligonucleosomes was used to detect
apoptosis using an ELISA kit (Cell Death Detection ELISA
Plus; Roche Molecular Biochemicals). Background values (incubation buffer alone) were subtracted, and OD values representing nucleosomal DNA fragments in treated samples were compared with those values obtained from untreated control cells,
and expressed as fold increase. Duplicate wells were treated for
each experimental condition and ELISA was performed in duplicate for each treated well. For inhibition of NF-
B activation,
cells were pretreated with 50 µM of the NF-
B inhibitor, BAY
11-7082 (Biomol, Plymouth Meeting, PA) for 1 h, then stimulated with LPS or silica.
Electrophoretic Mobility Shift Assay
Pellets were resuspended in 150 µl lysis buffer (20 mM HEPES,
125 nM sodium chloride, 5 mM magnesium chloride, 12% vol/vol glycerol, 5 mM DTT, 0.5 mM PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin), sonicated on ice for 15 s, and centrifuged at 14,000 RPM at 4°C. Protein concentration was determined using a DC-BioRad protein assay (BioRad, Hercules, CA). For retardation
assays NF-
B consensus oligonucleotide 5'-AGT TGA GGG
GAC TTT CCC AGG C-3' (Santa Cruz, Santa Cruz, CA) was
end-labeled with [
-32P] ATP and T4 polynucleotide kinase
(Gibco BRL). 5 µg protein of crude nuclear extract was mixed with
the labeled probe and buffer (10 mM Hepes, 7.2% vol/vol glycerol, 3 mM magnesium chloride, 3 mM DTT, 3 µl Nonidet, 60 µg
BSA, 360 µg spermidine, 1.5 µg poly [dI-dC] in a 20 µl total volume) and incubated to allow binding to the probe. DNA-protein
complexes were separated on 6% polyacrylamide gels (Invitrogen, Carlsbad, CA), gels were vacuum-dried, and labeled complexes were detected by autoradiography.
Transient Transfections and Luciferase Assay
RAW 264.7 cells were transfected using lipofectamine reagent
(3 µl/µg DNA; Gibco BRL). In a standard experiment, cells
(60-80% confluence in 6-well plates) were transfected with 2 µg/well of reporter plasmid/well in OptiMEM I media (Gibco
BRL), using cis-reporter plasmids containing the luciferase reporter gene driven by a basic promoter element (TATA box)
joined to tandem repeats of NF-
B (Stratagene, La Jolla, CA),
or by pTNF (
1185), pTNF (
615), and pTNF (
36), three truncated TNF promoters, previously described and kindly provided
by Dr. J. S. Economou (30). Following a 6-h incubation at 37°C
in a 5% CO2 incubator, the media was replaced with DMEM media,
and cells were stimulated with silica (0.1 and 0.2 mg/ml), or with
LPS (2 µg/ml) or 4
Phorbol 12 myristate 13acetate (PMA; 20 ng/ml) as positive controls. Untreated transfected cells served
as a control. Luciferase gene expression was assayed using a Luciferase Assay System kit (Promega, Madison, WI) and compared with Luciferase expression in transfected untreated control cells.
Data Analysis
Experiments were replicated three to five times to ensure reproducibility. Within each culture trial, each condition was performed in duplicate, and numbers generated by each condition were averaged and treated as individual results. For gel data analyses, the bands corresponding to each transcription factor of interest were scanned and the dynamic range of the grayscale was examined by pixel histogram to prevent saturation. Numeric data were subjected to two-way ANOVA followed by Newman-Keuls post hoc tests for multiple comparisons or summary t tests as appropriate. A P value < 0.05 was considered to be statistically significant.
| |
Results |
|---|
|
|
|---|
Induction of Apoptosis in RAW 264.7 and IC-21 Macrophages
Silica stimulation (0.2 or 1 mg/ml) for 6 h resulted in increased apoptosis in both the RAW 264.7 and IC-21
macrophages. However, the magnitude of the apoptotic
response was significantly higher in RAW 264.7 compared
with IC-21 cells (Figure 1; P < 0.05). In contrast, LPS
treatment did not induce apoptosis in any of the two cell
lines (Figure 1). Inhibition of NF-
B by pretreatment with
50 µM BAY-11-7082, an inhibitor of I
B phosphorylation, resulted in a significant increase of apoptosis in RAW
264.7 untreated cells, as well as in LPS- and silica-treated
cells (Figure 1). However, there was no additional increase
in apoptosis after silica or LPS treatment in RAW 264.7 macrophage pretreated with BAY 11-7082, suggesting
that inhibition of NF-
B stimulates peak levels of apoptosis that cannot be enhanced by silica proapoptotic
stimulation (Figure 1). In contrast, addition of BAY 11-
7082 to IC-21 cells inhibited silica-induced apoptotic response (Figure 1). These data suggest that RAW 264.7 macrophages are more sensitive to silica injury than IC-21.
In addition, the reduced apoptotic response to silica in
IC-21 cells pretreated with the NF-
B inhibitor indicates that in these cells, baseline levels of NF-
B activity are
required for the induction of an apoptotic response to silica. This observation contrasts with NF-
B activation of
antiapoptotic pathways in RAW 264.7 cells.
|
NF-
B Activation in RAW 264.7 and IC-21 Macrophages
To investigate whether differences in NF-
B activation
could account for the differences in induction of apoptosis
by silica in the two cell lines, we examined NF-
B activation after silica or LPS stimulation in both cell lines.
EMSA showed that NF-
B DNA binding activity increased in RAW 264.7 macrophages at 6 h exposure to silica (0.2 or 1 mg/ml) or LPS (2 µg/ml), and this increase
was attenuated by pretreatment with the NF-
B antagonist, BAY-11-7082 (Figure 2).
|
To further confirm that silica-induced activation of NF-
B
results in stimulation of gene transcription, we examined
silica- and LPS-induced activation of luciferase transcription driven by a NF-
B-dependent promoter, using PMA
stimulation as a positive control. Silica-induced NF-
B-
driven luciferase expression in RAW 264.7 cells was comparable to that stimulated by LPS (2 µg/ml) or PMA (20 ng/ml; Figure 3). Unlike RAW 264.7 cells, electromobility shift assays did not show increased nuclear binding of NF-
B
in silica-treated IC-21 macrophages at 6 h. Longer exposures of IC-21 cells to silica up to 24 h also failed to induce
NF-
B binding to DNA in these cells (Figure 2). In contrast, LPS elicited significant increases in NF-
B DNA
binding (Figure 2). These findings suggest that RAW 264.7 macrophages, but not IC-21 macrophages, activate NF-
B-dependent transcription in response to silica stimulation. However, both cell types can induce NF-
B when
treated with LPS, indicating that the disparity in NF-
B
activation between the two cell lines is specific to silica
stimulation.
|
Induction of TNF-
Secretion in RAW 264.7 and IC-21 Macrophages
TNF-
induction and NF-
B activation have previously
been implicated in silica injury (4, 10, 27, 28). To examine whether TNF-
induction is related to silica stimulation of
apoptosis in RAW 264.7 and IC-21 macrophages, we stimulated both of these cell lines for 6 or 24 h, and determined
TNF-
protein expression with a TNF-
ELISA. In the
presence of silica doses sufficient to induce apoptosis in
these cells, stimulation of RAW 264.7 macrophages resulted in increased TNF-
release, with maximal TNF-
levels occurring at 6 h (Figure 4). Interestingly, 24 h exposure to silica using the higher silica concentration (1 mg/ml)
did not induce a TNF-
response as robust as that observed at 6 h, possibly because of extensive cell death.
|
Pre-treatment of RAW 264.7 cells with 50 µM BAY
11-7082 inhibited silica-induced TNF-
secretion at 6 or
24 h (Figure 4; P < 0.05). In contrast, no TNF-
release
occurred at either 6 or 24 h of silica stimulation in IC-21
macrophages (Figure 4). However, treatment with LPS (2 µg/ml) stimulated TNF-
secretion in both cell lines, albeit
with a smaller response in IC-21 compared with RAW
264.7 cells (Figure 4). In this setting, NF-
B inhibition of
RAW 264.7 cells resulted in no induction of TNF-
release
following LPS exposure (Figure 4). Thus, abolition of silica- or LPS-stimulated TNF-
release by NF-
B inhibition
in RAW 264.7 cells suggests that NF-
B activation is critical to the induction of TNF-
. In addition, the absence of
TNF-
release in silica-stimulated IC-21 cells along with
absent NF-
B activation further reinforces such a putative
role of NF-
B.
Silica Induction of TNF-
Promoter Activity
in RAW 264.7 Cells
To examine the role of silica in the activation of the TNF-
promoter, we further examined whether silica stimulation
of RAW 264.7 cells induces the transcription of a luciferase gene driven by a TNF-
promoter. In addition, we
studied whether modifications of this promoter will affect
silica-induced transcriptional activation of the TNF-
promoter-driven gene. RAW 264.7 cells were transfected with
a luciferase gene driven by three truncated TNF-
promoters, as previously described by Rhoades and coworkers (30): (i) pTNF (-1185) is a virtually complete TNF-
promoter, containing four NF-
B-binding sites as well as
the AP-1-, Sp1/Egr-1-, Ets-, CRE-, and AP-2-binding
sites; (ii) pTNF (
615) contains three NF-
B-binding sites,
as well as all the additional transcription factors' binding sites; (iii) pTNF (
36) served as a negative control, and is
a truncated TNF-
promoter containing only the AP-2-
binding site.
Silica stimulation (0.1 and 0.2 mg/ml) of RAW 264.7 cells induced a 2-fold increase in pTNF (
1185) or pTNF
(
615) promoter transcriptional activity (Figure 5). Similarly, LPS (2 mg/ml) and PMA (20 ng/ml) stimulations resulted in 6- and 3-fold increases, respectively, in luciferase
expression driven by pTNF (
1185) promoter. There
were no significant differences between silica-, PMA-, and
LPS-induced luciferase expression when driven by the pTNF (
1185) and the pTNF (
615) promoters. However, neither LPS, silica, nor PMA induced luciferase expression when luciferase transcription was driven by the
pTNF (
36) negative control. These findings indicate that
silica induces TNF-
gene transcription. In addition, binding to the promoter of the TNF-
gene by multiple transcription factors is essential to TNF-
induction by LPS, silica, or PMA in RAW 264.7 macrophages. However, the
fourth distal NF-
B-binding site is not essential for activation of TNF-
gene transcription.
|
| |
Discussion |
|---|
|
|
|---|
Silica exposure induces the development of granulomatous inflammation and fibrosis in the lung. Initial recruitment of macrophages is followed by an extensive inflammatory response characterized by the release of cytokines,
NF-
B activation and induction of apoptosis (8, 15, 26, 31-
33). In a recently published study of in vivo silica induction
of apoptosis in mice lung sections, peak apoptosis was detected at 1 and 6 wk of silica exposure, when silicotic lesions start to form, diminishing by 12 wk after silica exposure, when large silicotic lesions are already present (34). Previously published observations reported that apoptotic
macrophages were present in rat lung 10 d after intratracheal silica instillation, and that 56 d later, apoptosis was
detected in granulomatous cells of lung tissue (12). In contrast, a study of histopathologic changes in rat lymph
nodes from 2 to 52 wk after silica exposure, reported granuloma-like structure and macrophage recruitment without signs of apoptosis (35). These observations suggest that macrophage apoptosis is an early event in lung pathogenesis of
silicosis. In contrast, induction of apoptosis and subsequent
removal of apoptotic cells by recruited macrophages, in response to acute pulmonary inflammation as an inflammation
clearing process in the lung, may suggest that the apoptotic
process contributes to the repair process (36). Silica-induced
alveolar macrophage apoptosis is mediated via a class A
scavenger receptor. A unique function of this receptor,
apart from its ability to bind silica, is the recognition and
clearance of negatively-charged inhaled particles as well as
the mediation and regulation of macrophage apoptosis
(32, 37) In summary, current in vivo time-course studies
indicate a critical role for macrophage apoptosis in the development of lung silicosis, but the signaling pathways involved in this pathogenesis have not yet been fully characterized. The apoptotic response occurring at an early stage
in the development of silicosis may represent an attempt
to remove injured cells and clear inflammation, resulting
in tissue remodeling and preservation of lung function.
Following this initial response, subsequent development of
silicosis may occur as macrophage apoptosis increases, affecting the removal of injured cells and tissue remodeling. To study the pathways implicated in silica-induced macrophage apoptosis, we identified two different cell lines of
murine macrophages that differ in their sensitivity to silica,
and established relationships between silica induction of
TNF-
, NF-
B activation, and apoptosis in the more sensitive RAW 264.7 cell line, compared with the more resistant IC-21 cell line. Silica stimulation of RAW 264.7 macrophages led to TNF-
release and increased NF-
B DNA
binding. Inhibition of NF-
B inhibited TNF-
release and
induced a significant increase in silica-induced apoptosis in
RAW 264.7 cells, suggesting that NF-
B activation is essential to TNF-
induction, and plays an antiapoptotic
role in these cells. In contrast, silica-exposed IC-21 macrophages did not release TNF-
, and did not induce
NF-
B DNA binding above baseline binding levels. Moreover, in contrast with RAW 264.7 cells, inhibition of this
baseline NF-
B activity in IC-21 cells prevented silica induction of apoptosis. The discrepancy in the cellular response between these two cell lines appears to be specific
to silica, because LPS stimulation induced TNF-
release
and NF-
B DNA binding in both cell lines.
Activation of NF-
B can be induced by a wide variety
of signals and may act as either a promoter or attenuator
of apoptosis (22, 38). NF-
B activation by proapoptotic stimuli led to the speculation that this transcription
factor is implicated in the induction of programmed cell
death. In contrast, another large body of literature has implicated NF-
B in survival pathways (22, 23, 39, 40). More
specifically, TNF receptors can induce apoptosis via a NF-
B
activating pathway, and NF-
B activation induces antiapoptotic genes to downregulate the ability of TNF-
to induce apoptosis (20, 23, 39). Recent evidence suggests that
NF-
B activation inhibits apoptosis in mouse embryonic
fibroblasts via modulation of JNK activity as well as induction of antiapoptotic proteins XIAP, c-IAP-1, c-FLIP, Bcl-xL,
and Bcl-2 (41). Similar observations were reported in a fibrosarcoma cell line with NF-
B induction of TRAF1 and
TRAF2, in turn activating c-IAP1 and cIAP2 inhibitors of
caspase 8 activation in the TNF-
signaling cascade (42).
In agreement with these reports, our study demonstrated that inhibition of NF-
B in RAW 264.7 cells resulted in an
increased apoptotic response, even in the absence of a
proapoptotic stimulus. In contrast, NF-
B inhibition in
IC-21 cells affecting baseline levels of NF-
B activation
decreased silica-induced apoptotic response in these cells.
These data suggest that NF-
B activity is required to prevent cell targeting into programmed cell death in silica-sensitive RAW 264.7 cells. However, a baseline NF-
B activity may be required for silica induction of apoptosis, as apparent in IC-21 cells. In addition, in RAW 264.7 cells,
the more robust silica response may induce proapoptotic
pathways as well as further activation of NF-
B to protect
the cells from both TNF-
- and silica-induced injury.
NF-
B inhibition resulted in the inhibition of silica- as
well as of LPS-induced TNF-
release, suggesting that in
addition to its antiapoptotic role, NF-
B activation is also
involved in the induction of TNF-
. Luciferase reporter gene
experiments performed in this study using RAW 264.7 cells confirmed that similar to LPS and PMA, silica was
able to induce the TNF-
promoter via a NF-
B-dependent
pathway, and that activation of three out of the four NF-
B-binding sites in the TNF-
promoter is sufficient for
the activation of TNF-
gene transcription in RAW 264.7 murine macrophages. Thus, in RAW 264.7 macrophages,
NF-
B can either become proapoptotic by inducing TNF-
transcription, or antiapoptotic, possibly dependent on the
magnitude of NF-
B activation. Conversely, TNF-
may
both increase silica-induced apoptosis and stimulate antiapoptotic signaling pathways by inducing NF-
B to protect the cells from more extensive apoptosis. We therefore
propose that the balance between NF-
B activity and
TNF-
expression will decide cell fate, such that strategies
that either induce or inhibit NF-
B activation may lead to
similar antiapoptotic effects, depending on the background
levels of NF-
B activity and TNF-
expression.
Silica exposure of IC-21 macrophages failed to induce
TNF-
release or NF-
B activation. Thus, silica induction
of apoptosis in IC-21 cells does not appear to be mediated
by a TNF-
-dependent pathway, and does not recruit
NF-
B. The relatively reduced apoptosis levels induced by
silica in IC-21 cells could be accounted for by the absence
of a TNF-
response. If so, this observation would concur
with published in vivo findings, whereby decreased pulmonary injury occurred in silica-exposed TNF-receptor KO
mice (27). The possibility exists, however, that factors acting upstream of TNF-
may explain IC-21 response characteristics to silica. For example, the proapoptotic Fas/Fas
Ligand (FasL) signaling pathway has been implicated in
silica induction of apoptosis in alveolar macrophages (15).
When FasL binds to its membrane receptor, which belongs
to the TNF-receptor family, it will induce apoptosis by activating a caspase-dependent cascade (reviewed in Ref.
43). Indeed, silica stimulation has been shown to fail to induce TNF-
and pulmonary fibrosis in FasL-deficient
mice (15). Thus, the relatively low silica induction of apoptosis in IC-21 cells suggests that these cells may have reduced FasL expression and/or that alternate apoptotic pathways are activated following silica exposure. Alternatively,
recently published data using IC-21 cells implicates another proinflammatory cytokine, interleukin (IL)-1
, as
well as nitric oxide synthase in the development of apoptosis
and lung inflammation, and demonstrates that silica-induced
apoptosis may be inhibited with a nitric oxide synthase inhibitor, or with an antibody to IL-1
(34). In addition,
these authors detected minimal apoptotic lesions in the
lungs of iNOS
/
and IL-1
/
mice, consistent with a role
for IL-1
and nitric oxide synthase in the in vivo induction
of apoptosis by silica (34). NF-
B DNA-binding sites are
present in both IL-1
and iNOS promoters and inhibition
of baseline levels of NF-
B activation in IC-21 cells may
affect this proinflammatory pathway (44).
There is an increasing body of evidence that LPS can
induce apoptosis. For example, increased apoptotic cell
death occurred after LPS in endothelial cells (47, 48), and
in hepatocytes (49). A substantial component of LPS proapoptotic role has been attributed to TNF-
and NF-
B induction (11, 23, 50). However, the TNF-
/NF-
B response
cannot explain the disparities in cellular apoptosis following LPS stimulation. In the present study, although both
LPS and silica were able to stimulate TNF-
secretion and NF-
B activation in RAW 264.7 macrophages, only silica
induced apoptosis in this cell line. These observations suggest that TNF-
and NF-
B may only contribute to silica-induced apoptosis in RAW 264.7 macrophages, and one or
more additional factors induced by silica exposure are essential to proapoptotic effect. In support of this observation, IC-21 had a diminished silica-induced apoptotic response and no TNF-
/NF-
B induction. Concurrent with
those studies supporting a proapoptotic role for LPS, a substantial number of studies suggest that LPS may also induce antiapoptotic pathways to counterbalance the proapoptotic effects of TNF-
. The higher levels of TNF-
protein and of NF-
B nuclear activity induced by LPS in
RAW 264.7 cells could have induced an antiapoptotic response to the initial proapoptotic effects of TNF-
and
NF-
B responses. Thus, the early proapoptotic response
would be superseded by a later antiapoptotic response,
both responses involving TNF-
protein and NF-
B nuclear activity. In support of this hypothesis, antiapoptotic
gene activation and induction of cellular inhibitors of
apoptosis by LPS have previously been reported in myeloid
cells, human monocytes, and in J774.1 and U937 human
macrophages, as well as in HeLa cells (23, 51). Furthermore, LPS has been shown to degrade I
B-
and I
B-
,
leading to persistent NF-
B activation. This is in contrast
with short-lasting NF-
B activation induced by proapoptotic stimuli, in which I
B-
degradation is minimal (38,
52). In addition, several studies reported in macrophages
the induction of iNOS by LPS, leading to NO production, which in turn inhibits IL-1
production at the transcription
level via an NF-
B-mediated pathway, and may inhibit cytokine-dependent proinflammatory and proapoptotic responses (46, 55). Thus, the divergent apoptotic response to
LPS appears to preferentially involve antiapoptotic pathways in the case of RAW 264.7 and IC-21 macrophage cell
lines. Such responses may underlie a protective mechanism for macrophages whose physiologic role is to secrete proinflammatory mediators stimulating cell death during
inflammatory events, providing these cells with the ability
to trigger anticellular defense mechanisms without inducing their own death.
In summary, silica induces apoptosis in IC-21 cells independently from TNF-
and NF-
B activation, and may induce alternative pro- and antiapoptotic pathways. In contrast, silica substantially enhances apoptosis in RAW 264.7 cells via TNF-
and NF-
B-dependent pathways. In addition, LPS failure to induce apoptosis in both RAW 264.7 or IC-21 cells, despite potent TNF-
responses in both cell
types, further suggests that TNF-
signaling is not sufficient to induce apoptosis, but may be synergistic with
other silica-induced pathways to promote apoptosis in
RAW 264.7 cells. This novel cellular approach will allow the
elaboration of new strategies to study molecular mechanisms of cellular vulnerability and tolerance to silica injury.
Our current findings further stress the critical importance
of concomitant interactions among the various elements mediating the macrophage apoptotic cascade. These observations further imply that therapeutic strategies for silicosis should not target one signaling molecule, but rather a
signaling pathway.
| |
Footnotes |
|---|
Address correspondence to: Evelyne Gozal, Ph.D., Kosair Children's Hospital Research Institute, University of Louisville, 570 S. Preston Street, Suite 321, Louisville, KY 40202. E-mail: evelyne.gozal{at}louisville.edu
(Received in original form November 26, 2001 and in revised form March 20, 2002).
Abbreviations: TNF-enzyme-linked immunosorbent assay, ELISA; electrophoretic mobility shift assay, EMSA; interleukin, IL; lipopolysaccharide, LPS; nuclear factor
B, NF-
B; 4
phorbol 12 myristate 13 acetate,
PMA; tumor necrosis factor-
, TNF-
.
Acknowledgments:
The authors thank Dr. J. S. Economou, from the Department of Surgery, UCLA School of Medicine, Los Angeles, CA, for the generous gift of TNF-luciferase plasmids. This work was supported by grants from
NIH ES 08663, Department of Defense and the Wetmore Foundation.
| |
References |
|---|
|
|
|---|
1. Driscoll, K. E., R. C. Lindenschmidt, J. K. Maurer, J. M. Higgins, and G. Ridder. 1990. Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. Am. J. Respir. Cell Mol. Biol. 2: 381-390 .
2. Zhang, Y., T. C. Lee, B. Guillemin, M. C. Yu, and W. N. Rom. 1993. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150: 4188-4196 [Abstract].
3. Orfila, C., J. C. Lepert, S. Gossart, M. F. Frisach, C. Cambon, and B. Pipy. 1998. Immunocytochemical characterization of lung macrophage surface phenotypes and expression of cytokines in acute experimental silicosis in mice. Histochem. J. 30: 857-867 [Medline].
4. Piguet, P. F., M. A. Collart, G. E. Grau, A.-P. Sappino, and P. Vassalli. 1990. Requirement of tumor necrosis factor for development of silica-induced pumonary fibrosis. Nature 344: 245-247 [Medline].
5.
Miyazaki, Y.,
K. Araki,
C. Vesin,
I. Garcia,
Y. Kapanci,
J. A. Whitsett,
P.-F. Piguet, and
P. Vassalli.
1995.
Expression of a tumor necrosis factor-
transgene in murine lung causes lymphocytic and fibrosing alveolitis.
J.
Clin. Invest.
96:
250-259
.
6. Driscoll, K. E., and J. K. Maurer. 1991. Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity. Toxicol. Pathol. 19: 398-405 [Medline].
7. Savici, D., B. He, L. J. Geist, M. Monick, and G. W. Hunninghake. 1994. Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp. Lung Res. 20: 613-625 [Medline].
8. Segade, F., E. Claudio, K. Wrobel, S. Ramos, and P. Lazo. 1995. Isolation of nine gene sequences induced by silica in murine macrophages. J. Immunol. 154: 2384-2392 [Abstract].
9. Welgus, H. G., Z. Campbell, Z. Bar-Shavit, R. M. Senior, and S. L. Teitelbaum. 1985. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J. Clin. Invest. 76: 219-224 .
10.
Chen, F.,
S.-C. Sun,
D. C. Kuhn,
L. J. Gaydos, and
L. M. Demers.
1995a.
Essential role of NF-
B activation in silica-induced inflammatory mediator
production in macrophages.
Biochem. Biophys. Res. Commun.
214:
985-992
[Medline].
11.
Chen, F.,
D. C. Kuhn,
S.-C. Sun,
L. J. Gaydos, and
L. M. Demers.
1995b.
Dependence and reversa of nitric oxide production on NF-
B in silica and lipopolysaccharide-induced macrophages.
Biochem. Biophys. Res. Commun.
214:
839-846
[Medline].
12. Leigh, J., H. Wang, A. Bonin, M. Peters, and X. Ruan. 1997. Silica-induced apoptosis in alveolar and granulomatous cells in vivo. Environ. Health Perspect. 105: 1241-1245 .
13. Lim, Y., J. H. Kim, K. A. Kim, Y. M. Chang, B. Y. Park, B. Y. Ahn, and Y. G. Phee. 1999. Silica-induced apoptosis in vivo and in vitro. Toxicol. Lett. 108: 335-339 [Medline].
14. Tomokuni, A., T. Otsuki, Y. Isozaki, S. Kita, H. Ueki, M. Kusaka, T. Kishimoto, and A. Ueki. 1999. Serum levels of soluble Fas ligand in patient with silicosis. Clin. Exp. Immunol. 118: 441-444 [Medline].
15.
Borges, V. M.,
H. Falcao,
J. H. Leite-Junior,
L. Alvim,
G. P. Texeira,
M. Russo,
A. F. Nobrega,
M. F. Lopes,
P. M. Rocco,
W. F. Davidson,
R. Linden,
H. Yagita,
W. A. Zin, and
G. A. DosReis.
2001.
Fas ligand triggers
pumonary silicosis.
J. Exp. Med.
194:
155-163
16.
Collart, M. A.,
P. Baeuerle, and
P. Vassalli.
1990.
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four
kappa B-like motifs and of constitutive and inducible forms of NF-kappa
B.
Mol. Cell. Biol.
10:
1498-506
17.
Shakhov, A. N.,
M. A. Collart,
P. Vassalli,
S. A. Nedospasov, and
C. V. Jongeneel.
1990.
Kappa-B type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor
gene in
primary macrophages.
J. Exp. Med.
171:
35-47
18.
Leitman, D. C.,
R. J. C. Ribeiro,
E. R. Mackow,
J. D. Baxter, and
B. L. West.
1991.
Identification of a tumor necrosis factor-responsive element in
the tumor necrosis factor
gene.
J. Biol. Chem.
266:
9343-9346
19.
Yao, J.,
N. Mackman,
T. S. Edington, and
S.-T. Fan.
1997.
Lipopolysaccharide induction of the tumor necrosis factor-
promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kB transcription factors.
J.
Biol. Chem.
272:
17795-17801
20.
Claudio, E.,
F. Segade,
K. Wrobel,
S. Ramos,
R. Bravo, and
P. S. Lazo.
1996.
Molecular mechanisms of TNF-
cytotoxicity: Activation of NF-
B
and nuclear translocation.
Exp. Cell Res.
224:
63-71
[Medline].
21.
Grimm, S.,
M. K. A. Bauer,
P. A. Bauerle, and
K. Schulze-Osthoff.
1996.
Bcl-2 down-regulates the activity of transcription factor NF-
B induced
apoptosis.
J. Cell Biol.
134:
13-23
22.
Van Antwerp, D. J.,
S. J. Martin,
I. M. Verma, and
D. R. Green.
1998.
Inhibition of TNF-induced apoptosis by NF-
B.
Trends Cell Biol.
8:
107-111
.
[Medline]
23.
Manna, S. K., and
B. B. Aggarwal.
1999.
Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappa B activation and reactive
oxygen intermediates.
J. Immunol.
162:
1510-1518
24.
Kaltschmidt, B.,
C. Kaltschmidt,
T. G. Hofmann,
S. P. Hehner,
W. Droge, and
L. M. Schmitz.
2000.
The pro- or anti-apoptotic function of NF-
B is determined by the nature of the apoptotic stimulus.
Eur. J. Biochem.
267:
3828-3835
[Medline].
25. Callis, A. H., P. G. Sohnle, G. S. Mandel, I. Wiessner, and N. S. Mandel. 1985. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis. J. Lab. Clin. Med. 105: 547-553 [Medline].
26. Ohtsuka, Y., M. Munakata, H. Ukita, T. Takahashi, A. Satoh, Y. Homma, and Y. Kawakami. 1995. Increased susceptibility to silicosis and TNF-alpha production in C57/BL/6J mice. Am. J. Respir. Crit. Care Med. 152: 2144-2149 [Abstract].
27.
Ortiz, L. A.,
J. A. Lasky,
G. Lungarella,
E. Cavarra,
P. Martorana,
W. A. Banks,
J. J. Peschon,
H. L. Schmidts,
A. R. Brody, and
M. Friedman.
1999.
Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after
silica and bleomycin exposure and protection from lung injury in double
receptor knockout mice.
Am. J. Respir. Cell Mol. Biol.
20:
825-833
28.
Ortiz, L. A.,
J. A. Lasky,
E. Gozal,
V. Ruiz,
G. Lungarella,
E. Cavarra,
A. R. Brody,
M. Friedman,
A. Pardo, and
M. Selman.
2001.
Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.
Am. J. Respir.
Crit. Care Med.
163:
244-252
29. Claudio, E., F. Segade, K. Wrobel, S. Ramos, and P. S. Lazo. 1995. Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death. Am. J. Respir. Cell Mol. Biol. 13: 547-554 [Abstract].
30.
Rhoades, K. L.,
S. H. Golub, and
J. S. Economou.
1992.
The regulation of
the human tumor necrosis region in macrophage, T factor alpha promoter
cell, and B cell lines.
J. Biol. Chem.
267:
22102-22107
31.
Sarih, M.,
V. Souvannavong,
S. C. Brown, and
A. Adam.
1993.
Silica induces apoptosis in macrophages and the release of interleukin-1
and interleukin-1
.
J. Leukoc. Biol.
54:
407-413
[Abstract].
32. Hamilton, R. F., W. J. de Villiers, and A. Holian. 2000. Class A type II scavenger receptor mediates silica-induced apoptosis in Chinese hamster ovary cell line. Toxicol. Appl. Pharmacol. 15: 100-106 .
33.
Iyer, R., and
A. Holian.
1997.
Involvement of the ICE proteases in silica-induced
apoptosis in human alveolar macrophages.
Am. J. Physiol.
273:
L760-L767
34.
Srivasta, K. D.,
W. N. Rom,
J. Jagirdar,
T. A. Yie,
T. Gordon, and
K. M. Tchou-Wong.
2002.
Crucial role of interleukin-1
and nitric oxide synthase in silica-induced inflammation and apoptosis in mice.
Am. J. Respir.
Crit. Care Med.
165:
527-533
35. Friedetzky, A., H. Garn, A. Kirshner, and D. Gemsa. 1998. Histopathological changes in enlarged thoracic lymph nodes during the development of silicosis in rats. Immunobiology 199: 119-132 [Medline].
36. Ishii, Y., K. Hashimoto, A. Nomura, T. Sakamoto, Y. Uchida, M. Ohtsuka, S. Hasegawa, and M. Sagai. 1998. Elimination of neutrophils by apoptosis during the resolution of acute pulmonary inflammation in rats. Lung 176: 89-98 [Medline].
37. Chao, S. K., R. F. Hamilton, J. C. Pfau, and A. Holian. 2001. Cell surface regulation of silica-induced apoptosis by the SR-A scavenger receptor in a murine lung macrophage cell line (MH-S). Toxicol. Appl. Pharmacol. 174: 10-16 [Medline].
38. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. I- kappaB-beta regulates the persistent response in a biphasic activation of NF-kappaB. Cell 80: 573-582 [Medline].
39. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 87: 565-576 [Medline].
40.
Wang, C.-Y.,
M. W. Mayo, and
A. S. Baldwin Jr..
1996.
TNF- and cancer
therapy-induced apoptosis: potentiation by inhibition of NF-
B.
Science
274:
784-787
41.
Tang, G.,
Y. Minemoto,
B. Dobling,
N. H. Purcell,
Z. Li,
M. Karin, and
A. Lin.
2001.
Inhibition of JNK activation through NF-
B target genes.
Nature
414:
313-317
[Medline].
42.
Wang, C. Y.,
M. W. Mayo,
R. G. Korneluk,
D. V. Goeddel, and
A. S. Baldwin Jr..
1998.
NF-
B antiapoptosis: induction of TRAF1 and TRAF2
and cIAP1 and cIAP2 to suppress caspase-8 activation.
Science
281:
1680-1683
43. Nagata, S.. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33: 29-55 [Medline].
44.
Baldwin, A. S. Jr..
1996.
The NF-
B and I
B proteins: new discoveries and
insights.
Annu. Rev. Immunol.
14:
649-681
[Medline].
45.
Blackwell, T. S., and
J. W. Christman.
1997.
The role of nuclear factor
B in
cytokine gene regulation.
Am. J. Respir. Cell Mol. Biol.
17:
3-9
46.
Schroeder, R. A.,
C. Cai, and
P. C. Kuo.
1999.
Endotoxin-mediated nitric
oxide synthesis inhibits IL-1
gene transcription in ANA-1 murine macrophages.
Am. J. Physiol.
277:
C523-530
47.
Messner, U. K.,
J. C. Reed, and
B. Brune.
1996.
Bcl-2 protects macrophages
from nitric oxide-induced apoptosis.
J. Biol. Chem.
271:
20192-20197
48.
Choi, K. B.,
F. Wong,
J. M. Harlan,
P. M. Chaudhary,
L. Hood, and
A. Karsan.
1998.
Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway.
J. Biol. Chem.
273:
20185-20188
49. Hamada, E., T. Nishida, Y. Uchiyama, J. Nakamura, K. Isahara, H. Kazuo, T. P. Huang, T. Momoi, T. Ito, and H. Matsuda. 1999. Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptotsis induced by endotoxin. J. Hepatol. 30: 807-818 [Medline].
50.
McDonald, T. E.,
M. N. Grinman,
C. M. Carthy, and
K. R. Walley.
2000.
Endotoxin infusion in rats induces apoptotic and survival pathways in
hearts.
Am. J. Physiol. Heart Circ. Physiol.
279:
H2053-H2061
51.
Perera, L. P., and
T. A. Waldmann.
1998.
Activation of human monocytes
induces differential resistance to apoptosis with rapid down regulation of
caspase-8/FLICE.
Proc. Natl. Acad. Sci. USA
95:
14308-14313
52.
Ruckdeschel, K.,
S. Harb,
A. Roggenkamp,
M. Hornef,
R. Zumbihl,
S. Kohler,
J. Heesemann, and
B. Rouot.
1998.
Yersinia enterocolitica impairs activation
of transcription factor NF-[kappa]B: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis
factor [alpha] production.
J. Exp. Med.
187:
1069-1079
53. Muro, M., K. Nakashhima, J. Tomioka, S. Kato, K. Nonaka, T. Yoshida, M. Inoue, T. Nishihara, and Y. Kowasashi. 1999. Inhibitory effect of lipopolysaccharide on apoptotic cell death in macrophages infected with Actinobacillus actinomycetemcomitans. FEMS Microbiol. Lett. 175: 211-216 .
54. Cui, X., T. Imaizumi, H. Yoshida, K. Tanji, T. Matsumiya, and K. Satoh. 2000. Lipopolysacharide induces the expression of cellular inhibitor of apoptosis protein-2 in human macrophages. Biochim. Biophys. Acta 1524: 178-182 [Medline].
55.
Schilling, D.,
T. Beissert,
M. J. Fenton, and
K. Nixdorff.
2001.
Negative regulation of IL-1
production at the level of transcription in macrophages
stimulated with LPS.
Cytokine
16:
51-61
[Medline].
This article has been cited by other articles:
![]() |
T. Sato, T. Shimosato, W. G. Alvord, and D. M. Klinman Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary Inflammation J. Immunol., June 1, 2008; 180(11): 7648 - 7654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Beamer and A. Holian Antigen-Presenting Cell Population Dynamics during Murine Silicosis Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 729 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Rasoulpour and K. Boekelheide NF-{kappa}B Is Activated in the Rat Testis Following Exposure to Mono-(2-Ethylhexyl) Phthalate Biol Reprod, February 1, 2005; 72(2): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Albrecht, R. P. F. Schins, D. Hohr, A. Becker, T. Shi, A. M. Knaapen, and P. J. A. Borm Inflammatory Time Course after Quartz Instillation: Role of Tumor Necrosis Factor-{alpha} and Particle Surface Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 292 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hou, M. Eren, C. A. Painter, J. W. Covington, J. D. Dixon, J. A. Schoenhard, and D. E. Vaughan Tumor Necrosis Factor {alpha} Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor {kappa}B Site J. Biol. Chem., April 30, 2004; 279(18): 18127 - 18136. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||